StockData
BioCorRx Inc. logo

BioCorRx Inc. (BICX) stock

BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.25+0.00 (0.00%)

Close on Oct 19, 2026Market cap $7.30MP/E –Yield –

BioCorRx operating margin

Operating margin is operating income as a percentage of revenue.

BioCorRx's operating margin for the twelve months ending Sep 30, 2025 was -571.7%. For fiscal 2025 it was -606.0%, against -66829.8% the year before. The highest annual figure on record is -260.7% in fiscal 2014.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-606.0%+66223.8
FY2024Dec 31, 2024-66829.8%−62581.5
FY2023Dec 31, 2023-4248.3%−2051.4
FY2022Dec 31, 2022-2197.0%+9217.7
FY2021Dec 31, 2021-11414.7%−5304.8
FY2020Dec 31, 2020-6109.9%−3795.2
FY2019Dec 31, 2019-2314.7%−1086.5
FY2018Dec 31, 2018-1228.2%−788.3
FY2017Dec 31, 2017-439.8%−128.9
FY2016Dec 31, 2016-310.9%+242.5
FY2015Dec 31, 2015-553.4%−292.7
FY2014Dec 31, 2014-260.7%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-1666.0%−970.7
Q1 FY2026Mar 31, 2026-445.6%+33407.3
Q3 FY2025Sep 30, 2025-306.3%+26453.2
Q2 FY2025Jun 30, 2025-793.3%+3551.0
Q1 FY2025Mar 31, 2025-695.3%+8785.9
Q2 FY2024Jun 30, 2024-33853.0%−29030.4
Q1 FY2024Mar 31, 2024-26759.4%−24147.5
Q4 FY2023Dec 31, 2023-4344.2%+1137.2
Q3 FY2023Sep 30, 2023-9481.2%+1108.0
Q2 FY2023Jun 30, 2023-4822.5%+10776.2
Q1 FY2023Mar 31, 2023-2611.9%+5340.7
Q1 FY2022Mar 31, 2022-5481.4%+1405.3
Q2 FY2021Sep 30, 2021-10589.2%−4195.9
Q1 FY2021Mar 31, 2021-15598.7%−11485.3
Q4 FY2020Dec 31, 2020-7952.6%−5397.9
Q3 FY2020Sep 30, 2020-6886.7%−4984.6
Q2 FY2020Jun 30, 2020-6393.3%−3968.3
Q1 FY2020Mar 31, 2020-4113.5%−1845.5
Q4 FY2019Dec 31, 2019-2554.7%+1208.3
Q3 FY2019Sep 30, 2019-1902.1%−119.1
Q2 FY2019Jun 30, 2019-2425.0%−1673.6
Q1 FY2019Mar 31, 2019-2267.9%−1903.1
Q4 FY2018Dec 31, 2018-3763.0%−3139.4
Q3 FY2018Sep 30, 2018-1783.0%−1333.3
Q2 FY2018Jun 30, 2018-751.4%−377.8
Q1 FY2018Mar 31, 2018-364.8%−57.6
Q4 FY2017Dec 31, 2017-623.6%+168.6
Q3 FY2017Sep 30, 2017-449.6%−140.9
Q2 FY2017Jun 30, 2017-373.6%−154.2
Q1 FY2017Mar 31, 2017-307.2%−162.0
Q4 FY2016Dec 31, 2016-792.2%+157.6
Q3 FY2016Sep 30, 2016-308.7%–
Q2 FY2016Jun 30, 2016-219.4%–
Q1 FY2016Mar 31, 2016-145.2%–
Q4 FY2015Dec 31, 2015-949.8%–

More BioCorRx figures

See a number that looks wrong?